These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.


BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

146 related articles for article (PubMed ID: 34312800)

  • 1. Ampullary Neuroendocrine Tumors: Insight into a Rare Histology.
    Ruff SM; Standring O; Wu G; Levy A; Anantha S; Newman E; Karpeh MS; Nealon W; Deutsch GB; Weiss MJ; DePeralta DK
    Ann Surg Oncol; 2021 Dec; 28(13):8318-8328. PubMed ID: 34312800
    [TBL] [Abstract][Full Text] [Related]  

  • 2. Duodenal, ampullary, and pancreatic neuroendocrine tumors: Oncologic outcomes are driven by tumor biology and tissue of origin.
    Schmocker RK; Wright MJ; Ding D; Javed AA; Cameron JL; Lafaro K; Burns WR; He J; Wolfgang CL; Burkhart RA
    J Surg Oncol; 2021 Feb; 123(2):416-424. PubMed ID: 33125737
    [TBL] [Abstract][Full Text] [Related]  

  • 3. Clinical outcomes for neuroendocrine tumors of the duodenum and ampulla of Vater: a population-based study.
    Randle RW; Ahmed S; Newman NA; Clark CJ
    J Gastrointest Surg; 2014 Feb; 18(2):354-62. PubMed ID: 24114680
    [TBL] [Abstract][Full Text] [Related]  

  • 4. Surgical treatment of neuroendocrine tumors in the second portion of the duodenum: a single center experience and systematic review of the literature.
    Iwasaki T; Nara S; Kishi Y; Esaki M; Shimada K; Hiraoka N
    Langenbecks Arch Surg; 2017 Sep; 402(6):925-933. PubMed ID: 27915372
    [TBL] [Abstract][Full Text] [Related]  

  • 5. Endoscopic treatment of sporadic small duodenal and ampullary neuroendocrine tumors.
    Gincul R; Ponchon T; Napoleon B; Scoazec JY; Guillaud O; Saurin JC; Ciocirlan M; Lepilliez V; Pioche M; Lefort C; Adham M; Pialat J; Chayvialle JA; Walter T
    Endoscopy; 2016 Nov; 48(11):979-986. PubMed ID: 27494453
    [No Abstract]   [Full Text] [Related]  

  • 6. Duodenal neuroendocrine tumors: Somewhere between the pancreas and small bowel?
    Gamboa AC; Liu Y; Lee RM; Zaidi MY; Staley CA; Kooby DA; Winer JH; Shah MM; Russell MC; Cardona K; Maithel SK
    J Surg Oncol; 2019 Dec; 120(8):1293-1301. PubMed ID: 31621090
    [TBL] [Abstract][Full Text] [Related]  

  • 7. Neuroendocrine Tumors (NETs) of the Minor Papilla/Ampulla: Analysis of 16 Cases Underlines Homology With Major Ampulla NETs and Differences From Extra-Ampullary Duodenal NETs.
    Vanoli A; Albarello L; Uncini S; Fassan M; Grillo F; Di Sabatino A; Martino M; Pasquali C; Milanetto AC; Falconi M; Partelli S; Doglioni C; Schiavo-Lena M; Brambilla T; Pietrabissa A; Sessa F; Capella C; Rindi G; La Rosa S; Solcia E; Paulli M
    Am J Surg Pathol; 2019 Jun; 43(6):725-736. PubMed ID: 30913089
    [TBL] [Abstract][Full Text] [Related]  

  • 8. Duodenal neuroendocrine neoplasms on enhanced CT: establishing a diagnostic model with duodenal gastrointestinal stromal tumors in the non-ampullary area and analyzing the value of predicting prognosis.
    Feng N; Chen HY; Lu YF; Pan Y; Yu JN; Wang XB; Deng XY; Yu RS
    J Cancer Res Clin Oncol; 2023 Nov; 149(16):15143-15157. PubMed ID: 37634206
    [TBL] [Abstract][Full Text] [Related]  

  • 9. Is there an Optimal Surgical Approach to Neuroendocrine Tumors of the Ampulla? A Single Institution Experience Over 15 Years.
    Baptiste GG; Postlewait LM; Ethun CG; Le N; Russell MC; Kooby DA; Staley CA; Maithel SK; Cardona K
    Am Surg; 2016 Jul; 82(7):637-43. PubMed ID: 27457864
    [TBL] [Abstract][Full Text] [Related]  

  • 10. Periampullary adenocarcinoma: analysis of 5-year survivors.
    Yeo CJ; Sohn TA; Cameron JL; Hruban RH; Lillemoe KD; Pitt HA
    Ann Surg; 1998 Jun; 227(6):821-31. PubMed ID: 9637545
    [TBL] [Abstract][Full Text] [Related]  

  • 11. Association of Histopathologic Phenotype of Periampullary Adenocarcinomas With Survival.
    Williams JL; Chan CK; Toste PA; Elliott IA; Vasquez CR; Sunjaya DB; Swanson EA; Koo J; Hines OJ; Reber HA; Dawson DW; Donahue TR
    JAMA Surg; 2017 Jan; 152(1):82-88. PubMed ID: 27732711
    [TBL] [Abstract][Full Text] [Related]  

  • 12. Experience with 647 consecutive tumors of the duodenum, ampulla, head of the pancreas, and distal common bile duct.
    Michelassi F; Erroi F; Dawson PJ; Pietrabissa A; Noda S; Handcock M; Block GE
    Ann Surg; 1989 Oct; 210(4):544-54; discussion 554-6. PubMed ID: 2679459
    [TBL] [Abstract][Full Text] [Related]  

  • 13. Survival comparison between endoscopic and surgical resection for non-ampullary duodenal neuroendocrine tumor (1-2 cm).
    Xie J; Zhang Y; He M; Liu X; Xie P; Pang Y
    Sci Rep; 2022 Sep; 12(1):15339. PubMed ID: 36097200
    [TBL] [Abstract][Full Text] [Related]  

  • 14. Four Neuroendocrine Tumor Types and Neuroendocrine Carcinoma of the Duodenum: Analysis of 203 Cases.
    Vanoli A; La Rosa S; Klersy C; Grillo F; Albarello L; Inzani F; Maragliano R; Manca R; Luinetti O; Milione M; Doglioni C; Rindi G; Capella C; Solcia E
    Neuroendocrinology; 2017; 104(2):112-125. PubMed ID: 26910321
    [TBL] [Abstract][Full Text] [Related]  

  • 15. Factors influencing survival after resection for periampullary neoplasms.
    Bouvet M; Gamagami RA; Gilpin EA; Romeo O; Sasson A; Easter DW; Moossa AR
    Am J Surg; 2000 Jul; 180(1):13-7. PubMed ID: 11036132
    [TBL] [Abstract][Full Text] [Related]  

  • 16. Predictive factors of severe complications for ampullary, bile duct and duodenal cancers following pancreaticoduodenectomy: Multivariate analysis of a 10-year multicentre retrospective series.
    Bourgouin S; Ewald J; Mancini J; Moutardier V; Delpero JR; Le Treut YP
    Surgeon; 2017 Oct; 15(5):251-258. PubMed ID: 26711559
    [TBL] [Abstract][Full Text] [Related]  

  • 17. Ampullary Neuroendocrine Neoplasm: Clinicopathological Characteristics and Novel Endoscopic Entity.
    Matsumoto K; Fujimori N; Hata Y; Minoda Y; Murakami M; Teramatsu K; Takamatsu Y; Takeno A; Oono T; Ihara E; Nakata K; Nakamura M; Yamamoto T; Koga Y; Oda Y; Ito T; Ogawa Y
    Dig Dis; 2023; 41(2):316-324. PubMed ID: 35588707
    [TBL] [Abstract][Full Text] [Related]  

  • 18. Distribution and pathological features of pancreatic, ampullary, biliary and duodenal cancers resected with pancreaticoduodenectomy.
    Chandrasegaram MD; Chiam SC; Chen JW; Khalid A; Mittinty ML; Neo EL; Tan CP; Dolan PM; Brooke-Smith ME; Kanhere H; Worthley CS
    World J Surg Oncol; 2015 Feb; 13():85. PubMed ID: 25890023
    [TBL] [Abstract][Full Text] [Related]  

  • 19. Ampullary GIST tumor as an incidental finding after a cephalic duodenopancreatectomy due to a suspicion of a nonfunctional neuroendocrine tumor.
    Correa Bonito A; Cuartero Desviat B; Martínez Negro E; Acedo Fernández de Pedro F; Rodríguez Marín D; Marcello Fernández ME; Ochando Cerdán F; Martínez Cortijo S
    Rev Esp Enferm Dig; 2022 Aug; 114(8):495-496. PubMed ID: 35255702
    [TBL] [Abstract][Full Text] [Related]  

  • 20. A Multi-institutional Analysis of Duodenal Neuroendocrine Tumors: Tumor Biology Rather than Extent of Resection Dictates Prognosis.
    Margonis GA; Samaha M; Kim Y; Postlewait LM; Kunz P; Maithel S; Tran T; Berger N; Gamblin TC; Mullen MG; Bauer TW; Pawlik TM
    J Gastrointest Surg; 2016 Jun; 20(6):1098-105. PubMed ID: 27008594
    [TBL] [Abstract][Full Text] [Related]  

    [Next]    [New Search]
    of 8.